Filing Details

Accession Number:
0001655759-25-000048
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-25 06:31:41
Reporting Period:
2025-02-24
Filing Date:
2025-02-25
Accepted Time:
2025-02-25 06:31:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753537 G John Houston C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-24 26,184 $16.75 1,162,634 No 4 S Direct
Common Stock Disposition 2025-02-24 5,154 $16.55 1,157,480 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on February 23, 2024.
  2. Includes an aggregate of 137 shares of the issuer's common stock purchased under and in accordance with the issuer's 2018 Employee Stock Purchaser Plan in transactions exempt under Rule 16b-3.
  3. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-quarter of the reporting person's RSUs granted on February 22, 2023.